Condition: Cerebral Aneurysm · Thromboembolic Disease · Sponsor: Hospital Universitario Central de Asturias
The use of flow-diverting stents for the endovascular treatment of cerebral aneurysms has proven to be effective and efficient in several clinical studies, leading to its widespread adoption. Devices with a higher number of filaments have a greater flow-diverting effect and less variation when there are changes in the caliber of the underlying vessel or in curved vessels. However, ischemic complications secondary to their implantation have been reported, prompting the development of various strategies to reduce their thrombogenicity. Phenox is the only company to date that has developed an anti-thrombogenic coating, known as HPC (Hydrophilic Polymer Coating), which, when applied to the p64 MW HPC and p48 MW HPC devices, has shown to reduce the likelihood of thromboembolic complications associated with their implantation.
This description comes directly from the study's public registry record.
PEDRO VEGA VALDES, MD, PhD · 0034985108000 · peveval@yahoo.es
Always discuss trial participation with your own doctor first.
| Hospital Universitario de A Coruña | A Coruña, Spain | Recruiting |
| Hospital Universitari Germans Trias I Pujol | Badalona, Spain | Recruiting |
| Hospital Universitari Vall D Hebron | Barcelona, Spain | Recruiting |
| Hospital Universitario de Burgos | Burgos, Spain | Recruiting |
| Hospital Universitario de Donostia | Donostia / San Sebastian, Spain | Recruiting |
| Hospital Universitario La Paz | Madrid, Spain | Recruiting |
| Hospital Regional Universitario de Malaga | Málaga, Spain | Recruiting |
| Hospital Universitario Central de Asturias | Oviedo, Spain | Recruiting |
| Hospital Parc Tauli | Sabadell, Spain | Recruiting |
| Hospital Clínico Universitario de Valladolid | Valladolid, Spain | Recruiting |
| Hospital Universitario Miguel Servet | Zaragoza, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06201598